Inhibition of platelet aggregation by anthrax edema toxin

Biochemical and Biophysical Research Communications

Volumn 339, Issue 1, 2006, Pages 107-114

  Alam, Sheeba ^a   Gupta, Megha ^a   Bhatnagar, Rakesh ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Bleeding time; Edema toxin; Hemorrhage; Platelet aggregation

Indexed keywords

ANTHRAX TOXIN;

ANIMAL CELL; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; EUKARYOTE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; WILD TYPE;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BLEEDING TIME; BLOOD PLATELETS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; MICE; PLATELET AGGREGATION; RABBITS; THROMBIN;

ANIMALIA; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); EUKARYOTA; ORYCTOLAGUS CUNICULUS;

EID: 28144431782     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.008     Document Type: Article

References (40)

1. R. Bhatnagar, and S. Batra Anthrax toxin Crit. Rev. Microbiol. 27 2001 167 200
2. N.S. Duesbery, C.P. Webb, S.H. Leppla, V.M. Gordon, K.R. Klimpel, T.D. Copeland, N.G. Ahn, M.K. Oskarsson, K. Fukasawa, K.D. Paull, and G.F. Vande Woude Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor Science 280 1998 734 737
3. S.H. Leppla Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Proc. Natl. Acad. Sci. USA 79 1982 3162 3166
4. N. Ahuja, P. Kumar, and R. Bhatnagar The adenylate cyclase toxins Crit. Rev. Microbiol. 30 2004 187 196
5. D.L. Hoover, A.M. Friedlander, L.C. Rogers, I.K. Yoon, R.L. Warren, and A.S. Cross Anthrax edema toxin differentially regulates lipopolysaccharide- induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP Infect. Immun. 62 1994 4432 4439
6. J. O'Brien, A. Friedlander, T. Dreier, J. Ezzell, and S. Leppla Effects of anthrax toxin components on human neutrophils Infect. Immun. 47 1985 306 310
7. P. Kumar, N. Ahuja, and R. Bhatnagar Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells Infect. Immun. 70 2002 4997 5007
8. A.G. Wu, D. Alibek, Y.L. Li, C. Bradburne, C.L. Bailey, and K. Alibek Anthrax toxin induces hemolysis: an indirect effect through polymorphonuclear cells J. Infect. Dis. 188 2003 1138 1141
9. T.C. Dixon, M. Meselson, J. Guillemin, and P.C. Hanna Anthrax N. Engl. J. Med. 341 1999 815 826
10. J.A. Jernigan, D.S. Stephens, D.A. Ashford, C. Omenaca, M.S. Topiel, M. Galbraith, M. Tapper, T.L. Fisk, S. Zaki, T. Popovic, R.F. Meyer, C.P. Quinn, S.A. Harper, S.K. Fridkin, J.J. Sejvar, C.W. Shepard, M. McConnell, J. Guarner, W.J. Shieh, J.M. Malecki, J.L. Gerberding, J.M. Hughes, and B.A. Perkins Anthrax bioterrorism investigation team, bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States Emerg. Infect. Dis. 7 2001 933 944
11. D.B. Jernigan, P.L. Raghunathan, B.P. Bell, R. Brechner, E.A. Bresnitz, J.C. Butler, M. Cetron, M. Cohen, T. Doyle, M. Fischer, C. Greene, K.S. Griffith, J. Guarner, J.L. Hadler, J.A. Hayslett, R. Meyer, L.R. Petersen, M. Phillips, R. Pinner, T. Popovic, C.P. Quinn, J. Reefhuis, D. Reissman, N. Rosenstein, A. Schuchat, W.J. Shieh, L. Siegal, D.L. Swerdlow, F.C Tenover, M. Traeger, J.W. Ward, and I. Weisfuse National anthrax epidemiologic investigation team, investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings Emerg. Infect. Dis. 8 2002 1019 1028
12. F.A. Abramova, L.M. Grinberg, O.V. Yampolskaya, and D.H. Walker Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979 Proc. Natl. Acad. Sci. USA 90 1993 2291 2294
13. L.M. Grinberg, F.A. Abramova, O.V. Yampolskaya, D.H. Walker, and J.H. Smith Quantitative pathology of inhalational anthrax I: quantitative microscopic findings Mod. Pathol. 14 2001 482 495
14. L. Borio, D. Frank, V. Mani, C. Chiriboga, M. Pollanen, M. Ripple, S. Ali, C. DiAngelo, J. Lee, J. Arden, J. Titus, D. Fowler, T. O'Toole, H. Masur, J. Bartlett, and T. Inglesby Death due to bioterrorism-related inhalational anthrax: report of 2 patients JAMA 286 2001 2554 2559
15. T.A. Mayer, S. Bersoff-Matcha, C. Murphy, J. Earls, S. Harper, D. Pauze, M. Nguyen, J. Rosenthal, D. Cerva Jr, G. Druckenbrod, D. Hanfling, N. Fatteh, A. Napoli, A. Nayyar, and E.L. Berman Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients JAMA 286 2001 2549 2553
16. S.W. Chensue Exposing a killer: pathologists angle for anthrax Am. J. Pathol. 163 2003 1699 1702
17. W.J. Shieh, J. Guarner, C. Paddock, P. Greer, K. Tatti, M. Fischer, M. Layton, M. Philips, E. Bresnitz, C.P. Quinn, T. Popovic, B.A. Perkins, and S.R. Zaki Anthrax bioterrorism investigation team. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax Am. J. Pathol. 163 2003 1901 1910
18. J. Guarner, J.A. Jernigan, W.J. Shieh, K. Tatti, L.M. Flannagan, D.S. Stephens, T. Popovic, D.A. Ashford, B.A. Perkins, and S.R. Zaki Inhalational anthrax pathology working group. Pathology and pathogenesis of bioterrorism-related inhalational anthrax Am. J. Pathol. 163 2003 701 709
19. N.C. Culley, D.M. Pinson, A. Chakrabarty, M.S. Mayo, and S.M. Levine Pathophysiological manifestations in mice exposed to anthrax lethal toxin Infect. Immun. 73 2005 7006 7010
20. C.R. Lyons, J. Lovchik, J. Hutt, M.F. Lipscomb, E. Wang, S. Heninger, L. Berliba, and K. Garrison Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility Infect. Immun. 72 2004 4801 4809
21. M. Moayeri, D. Haines, H.A. Young, and S.H. Leppla Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice J. Clin. Invest. 112 2003 670 682
22. M. Iwaki, K. Kamachi, N. Heveker, and T. Konda Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin Infect. Immun. 67 1999 2763 2768
23. J.H. Kau, D.S. Sun, W.J. Tsai, H.F. Shyu, H.H. Huang, H.C. Lin, and H.H. Chang Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets J. Infect. Dis. 192 2005 1465 1474
24. R.H. Harris, P.W. Ramwell, and P.J. Gilmer Cellular mechanisms of prostaglandin action Annu. Rev. Physiol. 41 1979 653 668
25. U.R. Schwarz, U. Walter, and M. Eigenthaler Taming platelets with cyclic nucleotides Biochem. Pharmacol. 62 2001 1153 1161
26. N. Ahuja, P. Kumar, and R. Bhatnagar Rapid purification of recombinant anthrax protective antigen under nondenaturing conditions Biochem. Biophys. Res. Commun. 286 2001 6 11
27. P. Kumar, N. Ahuja, and R. Bhatnagar Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen Infect. Immun. 69 2001 6532 6536
28. N. Ahuja, P. Kumar, S. Alam, M. Gupta, and R. Bhatnagar Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo Biochem. Biophys. Res. Commun. 307 2003 446 450
29. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the Principle of protein-dye binding Anal. Biochem. 72 1976 248 254
30. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
31. Y. Yuan, S.M. Schoenwaelder, H.H. Salem, and S.P. Jackson The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase J. Biol. Chem. 271 1996 27090 27098
32. K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, H. Matsuo, and T. Eto Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma Biochem. Biophys. Res. Commun. 185 1992 134 141
33. G.V.R. Born Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 1962 927 929
34. H.C. Flick-Smith, N.J. Walker, P. Gibson, H. Bullifent, S. Hayward, J. Miller, R.W. Titball, and E.D. Williamson A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection Infect. Immun. 70 2002 1653 1656
35. A. Moers, B. Nieswandt, S. Massberg, N. Wettschureck, S. Gruner, I. Konrad, V. Schulte, B. Aktas, M.P. Gratacap, M.I. Simon, M. Gawaz, and S. Offermanns G13 is an essential mediator of platelet activation in hemostasis and thrombosis Nat. Med. 9 2003 1418 1422
36. U.R. Schwarz, A.L. Kobsar, M. Koksch, U. Walter, and M. Eigenthaler Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets Biochem. Pharmacol. 60 2000 1399 1407
37. R.J. Bodnar, X. Xi, Z. Li, M.C. Berndt, and X. Du Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta) J. Biol. Chem. 277 2002 47080 47087
38. M. Mazzucato, P. Pradella, M.R. Cozzi, L. De Marco, and Z.M. Ruggeri Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor Blood 100 2002 2793 2800
39. D.S. Sim, G. Merrill-Skoloff, B.C. Furie, B. Furie, and R. Flaumenhaft Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels Blood 103 2004 2127 2134
40. C. Pezard, P. Berche, and M. Mock Contribution of individual toxin components to virulence of Bacillus anthracis Infect. Immun. 59 1991 3472 3477